Research on Ferrina
Since the development of FERRINA, several studies have been conducted in order to assess the benefits of a formulation based on a particularly iron-rich spirulina.
Study in vitro on the ability of an iron-rich spirulina to contain pro-oxidant effects of iron
Hannaert and Garay (2000) demonstrated that our iron-rich spirulina behaved favorably compared to ferrous sulfate and ferrous gluconate in terms of generation of hydroxyl ions on a simulation model of gastric digestion.
Reducing pro-oxidant effects of iron during gastric digestion limit side effects and improve treatment adherence.
Clinical study on the absorption of iron from iron-rich spirulina on predialysis patients over a long period of treatment
Moscoso (2006) demonstrated the ability to absorb iron from our iron-rich including the stock ferritin for patients predialysisspirulina. He also demonstrated a dose-response relationship based on quantities of iron ingested.
Using a formulation of iron over long periods of time without significant side effects is particularly interesting for the chronically deficient in iron.
Comparative clinical study of side effects and treatment adherence on pregnant women
Barberis (2009) demonstrated that our iron-rich spirulina caused significantly fewer side effects than bisglycinate iron in pregnant women.
Poor adherence to treatment and discontinuation of therapy are the major causes for the failure of iron supplementation. Spirulina iron can overcome the problems associated with unwanted side effects of iron supplements synthesis.